{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:39:40Z","timestamp":1781278780690,"version":"3.54.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T00:00:00Z","timestamp":1698624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T00:00:00Z","timestamp":1698624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004697","name":"Hamadan University of Medical Sciences","doi-asserted-by":"publisher","award":["9904172448"],"award-info":[{"award-number":["9904172448"]}],"id":[{"id":"10.13039\/501100004697","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s11033-023-08888-2","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T12:01:43Z","timestamp":1698667303000},"page":"10047-10059","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["In vitro co-delivery of 5-fluorouracil and all-trans retinoic acid by PEGylated liposomes for colorectal cancer treatment"],"prefix":"10.1007","volume":"50","author":[{"given":"Zahra","family":"Azarifar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razieh","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Tanzadehpanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeid","family":"Afshar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1326-1288","authenticated-orcid":false,"given":"Rezvan","family":"Najafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,30]]},"reference":[{"key":"8888_CR1","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.2147\/IJN.S290263","volume":"16","author":"S Wang","year":"2021","unstructured":"Wang S, Gou J, Wang Y, Tan X, Zhao L, Jin X et al (2021) Synergistic antitumor efficacy mediated by liposomal co-delivery of polymeric micelles of vinorelbine and cisplatin in non-small cell lung cancer. Int J Nanomed 16:2357","journal-title":"Int J Nanomed"},{"key":"8888_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/5416923","volume":"2018","author":"LTH Phi","year":"2018","unstructured":"Phi LTH, Sari IN, Yang Y-G, Lee S-H, Jun N, Kim KS et al (2018) Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment. Stem Cells Int 2018:1\u201316","journal-title":"Stem Cells Int"},{"issue":"6","key":"8888_CR3","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s00280-019-03936-w","volume":"84","author":"V Sharma","year":"2019","unstructured":"Sharma V, Gupta SK, Verma M (2019) Dihydropyrimidine dehydrogenase in the metabolism of the anticancer drugs. Cancer Chemother Pharmacol 84(6):1157\u20131166","journal-title":"Cancer Chemother Pharmacol"},{"key":"8888_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111285","volume":"137","author":"C Sethy","year":"2021","unstructured":"Sethy C, Kundu CN (2021) 5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: implication of DNA repair inhibition. Biomed Pharmacother 137:111285","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"8888_CR5","doi-asserted-by":"publisher","first-page":"926","DOI":"10.3390\/cells8080926","volume":"8","author":"L Barbato","year":"2019","unstructured":"Barbato L, Bocchetti M, Di Biase A, Regad T (2019) Cancer stem cells and targeting strategies. Cells 8(8):926","journal-title":"Cells"},{"issue":"7","key":"8888_CR6","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.4103\/jcrt.JCRT_976_17","volume":"14","author":"Y Pan","year":"2018","unstructured":"Pan Y, Ma S, Cao K, Zhou S, Zhao A, Li M et al (2018) Therapeutic approaches targeting cancer stem cells. J Cancer Res Ther 14(7):1469\u20131475","journal-title":"J Cancer Res Ther"},{"key":"8888_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113451","volume":"220","author":"C Liang","year":"2021","unstructured":"Liang C, Qiao G, Liu Y, Tian L, Hui N, Li J et al (2021) Overview of all-trans-retinoic acid (ATRA) and its analogues: structures, activities, and mechanisms in acute promyelocytic leukaemia. Eur J Med Chem 220:113451","journal-title":"Eur J Med Chem"},{"key":"8888_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s11671-020-3293-3","volume":"15","author":"C Li","year":"2020","unstructured":"Li C, Han X (2020) Co-delivery of dacarbazine and all-trans retinoic acid (ATRA) using lipid nanoformulations for synergistic antitumor efficacy against malignant melanoma. Nanoscale Res Lett 15:1\u201310","journal-title":"Nanoscale Res Lett"},{"issue":"1","key":"8888_CR9","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1080\/10717544.2019.1580797","volume":"26","author":"M Lei","year":"2019","unstructured":"Lei M, Ma G, Sha S, Wang X, Feng H, Zhu Y et al (2019) Dual-functionalized liposome by co-delivery of paclitaxel with sorafenib for synergistic antitumor efficacy and reversion of multidrug resistance. Drug Delivery 26(1):262\u2013272","journal-title":"Drug Delivery"},{"issue":"2","key":"8888_CR10","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/cas.14256","volume":"111","author":"L Kong","year":"2020","unstructured":"Kong L, Cai FY, Yao XM, Jing M, Fu M, Liu JJ et al (2020) RPV-modified epirubicin and dioscin co-delivery liposomes suppress non-small cell lung cancer growth by limiting nutrition supply. Cancer Sci 111(2):621\u201336","journal-title":"Cancer Sci"},{"key":"8888_CR11","doi-asserted-by":"publisher","first-page":"5109","DOI":"10.2147\/IJN.S204221","volume":"14","author":"K Pal","year":"2019","unstructured":"Pal K, Madamsetty VS, Dutta SK, Mukhopadhyay D (2019) Co-delivery of everolimus and vinorelbine via a tumor-targeted liposomal formulation inhibits tumor growth and metastasis in RCC. Int J Nanomed 14:5109\u20135123","journal-title":"Int J Nanomed"},{"key":"8888_CR12","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.2147\/IJN.S290263","volume":"16","author":"S Wang","year":"2021","unstructured":"Wang S, Gou J, Wang Y, Tan X, Zhao L, Jin X et al (2021) Synergistic antitumor efficacy mediated by liposomal co-delivery of polymeric micelles of vinorelbine and cisplatin in non-small cell lung cancer. Int J Nanomed 16:2357\u20132372","journal-title":"Int J Nanomed"},{"key":"8888_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13346-020-00746-z","volume":"11","author":"X Wang","year":"2021","unstructured":"Wang X, Liu Y, Xu W, Jia L, Chi D, Yu J et al (2021) Irinotecan and berberine co-delivery liposomes showed improved efficacy and reduced intestinal toxicity compared with onivyde for pancreatic cancer. Drug Delivery Transl Res 11:1\u201312","journal-title":"Drug Delivery Transl Res"},{"issue":"9","key":"8888_CR14","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1080\/09205063.2020.1743946","volume":"31","author":"S Khaledi","year":"2020","unstructured":"Khaledi S, Jafari S, Hamidi S, Molavi O, Davaran S (2020) Preparation and characterization of PLGA-PEG-PLGA polymeric nanoparticles for co-delivery of 5-fluorouracil and chrysin. J Biomater Sci Polym Ed 31(9):1107\u20131126","journal-title":"J Biomater Sci Polym Ed"},{"issue":"2015","key":"8888_CR15","first-page":"286","volume":"6","author":"L Sercombe","year":"2015","unstructured":"Sercombe L, Veerati T, Moheimani F, Wu S, Sood A, Hua S (2015) Advances and challenges of liposome assisted drug delivery. Front Pharmacol 6(2015):286","journal-title":"Front Pharmacol"},{"issue":"12","key":"8888_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11051-022-05630-0","volume":"24","author":"H Tanzadehpanah","year":"2022","unstructured":"Tanzadehpanah H, Mahaki H, Manoochehri H, Soleimani M, Najafi R (2022) AS1411 aptamer improves therapeutic efficacy of PEGylated nanoliposomes loaded with gefitinib in the mice bearing CT26 colon carcinoma. J Nanopart Res 24(12):1\u201318","journal-title":"J Nanopart Res"},{"issue":"1","key":"8888_CR17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.2174\/1566524018666180416101522","volume":"18","author":"A Jain","year":"2018","unstructured":"Jain A, Jain S (2018) Advances in tumor targeted liposomes. Curr Mol Med 18(1):44\u201357","journal-title":"Curr Mol Med"},{"key":"8888_CR18","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.2217\/nnm.13.118","volume":"8","author":"P Deshpande","year":"2013","unstructured":"Deshpande P, Biswas S, Torchilin V (2013) Current trends in the use of liposomes for tumor targeting. Nanomedicine 8:1509\u20131528","journal-title":"Nanomedicine"},{"issue":"4","key":"8888_CR19","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s13139-019-00603-z","volume":"53","author":"W Lee","year":"2019","unstructured":"Lee W, Im H-J (2019) Theranostics based on liposome: looking back and forward. Nucl Med Mol Imaging 53(4):242\u2013246","journal-title":"Nucl Med Mol Imaging"},{"key":"8888_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2022.112714","volume":"218","author":"H Manoochehri","year":"2022","unstructured":"Manoochehri H, Jalali A, Tanzadehpanah H, Taherkhani A, Najafi R (2022) Aptamer-conjugated nanoliposomes containing COL1A1 siRNA sensitize CRC cells to conventional chemotherapeutic drugs. Colloids Surf B 218:112714","journal-title":"Colloids Surf B"},{"issue":"2","key":"8888_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0378-5173(99)00425-1","volume":"196","author":"B Pietzyk","year":"2000","unstructured":"Pietzyk B, Henschke K (2000) Degradation of phosphatidylcholine in liposomes containing carboplatin in dependence on composition and storage conditions. Int J Pharm 196(2):215\u2013218","journal-title":"Int J Pharm"},{"issue":"6","key":"8888_CR22","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/jps.1023","volume":"90","author":"T Lian","year":"2001","unstructured":"Lian T, Ho RJ (2001) Trends and developments in liposome drug delivery systems. J Pharm Sci 90(6):667\u2013680","journal-title":"J Pharm Sci"},{"key":"8888_CR23","doi-asserted-by":"publisher","DOI":"10.36468\/pharmaceutical-sciences.661","author":"P Gupta","year":"2020","unstructured":"Gupta P, Mazumder R, Padhi S (2020) Glycerosomes: advanced liposomal drug delivery system. Indian J Pharm Sci. https:\/\/doi.org\/10.36468\/pharmaceutical-sciences.661","journal-title":"Indian J Pharm Sci"},{"issue":"1","key":"8888_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/10717540490265243","volume":"11","author":"M Anderson","year":"2004","unstructured":"Anderson M, Omri A (2004) The effect of different lipid components on the in vitro stability and release kinetics of liposome formulations. Drug Delivery 11(1):33\u201339","journal-title":"Drug Delivery"},{"issue":"2","key":"8888_CR25","first-page":"265","volume":"12","author":"S Honary","year":"2013","unstructured":"Honary S, Zahir F (2013) Effect of zeta potential on the properties of nano-drug delivery systems-a review (Part 2). Trop J Pharm Res 12(2):265\u2013273","journal-title":"Trop J Pharm Res"},{"issue":"2","key":"8888_CR26","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.drudis.2016.11.005","volume":"22","author":"M Cagel","year":"2017","unstructured":"Cagel M, Grotz E, Bernabeu E, Moretton MA, Chiappetta DA (2017) Doxorubicin: nanotechnological overviews from bench to bedside. Drug Discovery Today 22(2):270\u2013281","journal-title":"Drug Discovery Today"},{"key":"8888_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.colsurfb.2019.04.035","volume":"180","author":"K Sen","year":"2019","unstructured":"Sen K, Banerjee S, Mandal M (2019) Dual drug loaded liposome bearing apigenin and 5-fluorouracil for synergistic therapeutic efficacy in colorectal cancer. Colloids Surf B 180:9\u201322","journal-title":"Colloids Surf B"},{"issue":"5","key":"8888_CR28","first-page":"245","volume":"2","author":"O Udofot","year":"2015","unstructured":"Udofot O, Affram K, Agyare E (2015) Cytotoxicity of 5-fluorouracil-loaded pH-sensitive liposomal nanoparticles in colorectal cancer cell lines. Integr Cancer Sci Ther 2(5):245","journal-title":"Integr Cancer Sci Ther"},{"key":"8888_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2022.106199","volume":"174","author":"L Zhang","year":"2022","unstructured":"Zhang L, Lin Z, Chen Y, Gao D, Wang P, Lin Y et al (2022) Co-delivery of docetaxel and resveratrol by liposomes synergistically boosts antitumor efficiency against prostate cancer. Eur J Pharm Sci 174:106199","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"8888_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s11671-020-3293-3","volume":"15","author":"C Li","year":"2020","unstructured":"Li C, Han X (2020) Co-delivery of dacarbazine and all-trans retinoic acid (ATRA) using lipid nanoformulations for synergistic antitumor efficacy against malignant melanoma. Nanoscale Res Lett 15(1):1\u201310","journal-title":"Nanoscale Res Lett"},{"issue":"7","key":"8888_CR31","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3390\/ph15070881","volume":"15","author":"T Chen","year":"2022","unstructured":"Chen T, Chen H, Jiang Y, Yan Q, Zheng S, Wu M (2022) Co-delivery of 5-fluorouracil and paclitaxel in mitochondria-targeted KLA-modified liposomes to improve triple-negative breast cancer treatment. Pharmaceuticals 15(7):881","journal-title":"Pharmaceuticals"},{"issue":"9","key":"8888_CR32","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1111\/jcmm.13110","volume":"21","author":"S Salatin","year":"2017","unstructured":"Salatin S, Yari KA (2017) Overviews on the cellular uptake mechanism of polysaccharide colloidal nanoparticles. J Cell Mol Med 21(9):1668\u20131686","journal-title":"J Cell Mol Med"},{"key":"8888_CR33","doi-asserted-by":"publisher","DOI":"10.15761\/ICST.1000150","author":"O Udofot","year":"2016","unstructured":"Udofot O, Affram K, Smith T, Tshabe B, Krishnan S, Sachdeva M et al (2016) Pharmacokinetic, biodistribution and therapeutic efficacy of 5-fluorouracil-loaded pH-sensitive PEGylated liposomal nanoparticles in HCT-116 tumor bearing mouse. J Nat Sci. https:\/\/doi.org\/10.15761\/ICST.1000150","journal-title":"J Nat Sci"},{"issue":"4","key":"8888_CR34","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1049\/nbt2.12028","volume":"15","author":"VMB Grace","year":"2021","unstructured":"Grace VMB, Wilson DD, Guruvayoorappan C, Danisha JP, Bonati L (2021) Liposome nano-formulation with cationic polar lipid DOTAP and cholesterol as a suitable pH-responsive carrier for molecular therapeutic drug (all-trans retinoic acid) delivery to lung cancer cells. IET Nanobiotechnol 15(4):380\u2013390","journal-title":"IET Nanobiotechnol"},{"key":"8888_CR35","doi-asserted-by":"publisher","first-page":"5681","DOI":"10.1007\/s00289-019-03039-9","volume":"77","author":"S Dhanavel","year":"2020","unstructured":"Dhanavel S, Praveena P, Narayanan V, Stephen A (2020) Chitosan\/reduced graphene oxide\/Pd nanocomposites for co-delivery of 5-fluorouracil and curcumin towards HT-29 colon cancer cells. Polym Bull 77:5681\u20135696","journal-title":"Polym Bull"},{"issue":"9","key":"8888_CR36","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nbt.3330","volume":"33","author":"E Blanco","year":"2015","unstructured":"Blanco E, Shen H, Ferrari M (2015) Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol 33(9):941\u2013951","journal-title":"Nat Biotechnol"},{"issue":"1","key":"8888_CR37","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"R Weinberg","year":"2000","unstructured":"Weinberg R, Hanahan D (2000) The hallmarks of cancer. Cell 100(1):57\u201370","journal-title":"Cell"},{"key":"8888_CR38","unstructured":"Sporn MB (1976) Approaches to prevention of epithelial cancer during the preneoplastic period. AACR"},{"key":"8888_CR39","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ejps.2017.05.038","volume":"105","author":"Y Yang","year":"2017","unstructured":"Yang Y, Lu X, Liu Q, Dai Y, Zhu X, Wen Y et al (2017) Palmitoyl ascorbate and doxorubicin co-encapsulated liposome for synergistic anticancer therapy. Eur J Pharm Sci 105:219\u2013229","journal-title":"Eur J Pharm Sci"},{"issue":"32","key":"8888_CR40","doi-asserted-by":"publisher","first-page":"19685","DOI":"10.1039\/C7RA01100H","volume":"7","author":"X Zhang","year":"2017","unstructured":"Zhang X, Liu Y, Kim YJ, Mac J, Zhuang R, Wang P (2017) Co-delivery of carboplatin and paclitaxel via cross-linked multilamellar liposomes for ovarian cancer treatment. RSC Adv 7(32):19685\u201319693","journal-title":"RSC Adv"},{"key":"8888_CR41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jconrel.2016.07.022","volume":"238","author":"B Zhang","year":"2016","unstructured":"Zhang B, Wang T, Yang S, Xiao Y, Song Y, Zhang N et al (2016) Development and evaluation of oxaliplatin and irinotecan co-loaded liposomes for enhanced colorectal cancer therapy. J Control Release 238:10\u201321","journal-title":"J Control Release"},{"key":"8888_CR42","doi-asserted-by":"publisher","first-page":"457","DOI":"10.2147\/IJN.S283793","volume":"16","author":"B Lian","year":"2021","unstructured":"Lian B, Wei H, Pan R, Sun J, Zhang B, Wu J et al (2021) Galactose modified liposomes for effective co-delivery of doxorubicin and combretastatin A4. Int J Nanomed 16:457\u201367","journal-title":"Int J Nanomed"},{"issue":"6","key":"8888_CR43","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/aps.2017.10","volume":"38","author":"X-j Kang","year":"2017","unstructured":"Kang X-j, Wang H-y, Peng H-g, Chen B-f, Zhang W-y, Wu A-h et al (2017) Codelivery of dihydroartemisinin and doxorubicin in mannosylated liposomes for drug-resistant colon cancer therapy. Acta Pharmacol Sin 38(6):885\u2013896","journal-title":"Acta Pharmacol Sin"},{"issue":"6","key":"8888_CR44","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1166\/nnl.2019.2950","volume":"11","author":"Z Wang","year":"2019","unstructured":"Wang Z, Du Y, He W, Zhou W, Xia Q, Li X (2019) Doxorubicin-loaded all-trans retinoic acid dimer phospholipid liposomes as co-delivery system to reverse drug resistance in breast cancer. Nanosci Nanotechnol Lett 11(6):749\u2013759","journal-title":"Nanosci Nanotechnol Lett"},{"key":"8888_CR45","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.colsurfb.2015.02.040","volume":"128","author":"HB Ruttala","year":"2015","unstructured":"Ruttala HB, Ko YT (2015) Liposomal co-delivery of curcumin and albumin\/paclitaxel nanoparticle for enhanced synergistic antitumor efficacy. Colloids Surf B 128:419\u2013426","journal-title":"Colloids Surf B"},{"issue":"1","key":"8888_CR46","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.xphs.2022.04.014","volume":"112","author":"Q Liu","year":"2023","unstructured":"Liu Q, Luo L, Gao X, Zhang D, Feng X, Yang P et al (2023) Co-Delivery of daunorubicin and homoharringtonine in folic acid modified-liposomes for enhancing therapeutic effect on acute myeloid leukemia. J Pharm Sci 112(1):123\u2013131","journal-title":"J Pharm Sci"},{"issue":"8","key":"8888_CR47","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1080\/1061186X.2017.1405426","volume":"26","author":"L Farahmand","year":"2018","unstructured":"Farahmand L, Darvishi B, Salehi M, Samadi Kouchaksaraei S, Majidzadeh-A K (2018) Functionalised nanomaterials for eradication of CSCs, a promising approach for overcoming tumour heterogeneity. J Drug Target 26(8):649\u2013657","journal-title":"J Drug Target"},{"issue":"2","key":"8888_CR48","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1136\/jclinpath-2017-204739","volume":"71","author":"MJ Munro","year":"2018","unstructured":"Munro MJ, Wickremesekera SK, Peng L, Tan ST, Itinteang T (2018) Cancer stem cells in colorectal cancer: a review. J Clin Pathol 71(2):110\u2013116","journal-title":"J Clin Pathol"},{"issue":"5","key":"8888_CR49","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s12094-011-0656-3","volume":"13","author":"R Perona","year":"2011","unstructured":"Perona R, L\u00f3pez-Ayll\u00f3n BD, de Castro CJ, Belda-Iniesta C (2011) A role for cancer stem cells in drug resistance and metastasis in non-small-cell lung cancer. Clin Transl Oncol 13(5):289\u2013293","journal-title":"Clin Transl Oncol"},{"issue":"3","key":"8888_CR50","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s13277-011-0155-8","volume":"32","author":"S Soltanian","year":"2011","unstructured":"Soltanian S, Matin MM (2011) Cancer stem cells and cancer therapy. Tumor Biol 32(3):425\u2013440","journal-title":"Tumor Biol"},{"issue":"7123","key":"8888_CR51","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature05372","volume":"445","author":"CA O\u2019Brien","year":"2007","unstructured":"O\u2019Brien CA, Pollett A, Gallinger S, Dick JE (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445(7123):106\u2013110","journal-title":"Nature"},{"issue":"6","key":"8888_CR52","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1053\/j.gastro.2009.12.063","volume":"138","author":"M Todaro","year":"2010","unstructured":"Todaro M, Francipane MG, Medema JP, Stassi G (2010) Colon cancer stem cells: promise of targeted therapy. Gastroenterology 138(6):2151\u20132162","journal-title":"Gastroenterology"},{"issue":"6","key":"8888_CR53","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.stem.2014.11.012","volume":"15","author":"A Zeuner","year":"2014","unstructured":"Zeuner A, Todaro M, Stassi G, De Maria R (2014) Colorectal cancer stem cells: from the crypt to the clinic. Cell Stem Cell 15(6):692\u2013705","journal-title":"Cell Stem Cell"},{"issue":"1","key":"8888_CR54","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/jcp.22213","volume":"225","author":"A Sengupta","year":"2010","unstructured":"Sengupta A, Cancelas JA (2010) Cancer stem cells: a stride towards cancer cure? J Cell Physiol 225(1):7\u201314","journal-title":"J Cell Physiol"},{"issue":"8","key":"8888_CR55","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.biopha.2014.10.019","volume":"68","author":"Z Kozovska","year":"2014","unstructured":"Kozovska Z, Gabrisova V, Kucerova L (2014) Colon cancer: cancer stem cells markers, drug resistance and treatment. Biomed Pharmacother 68(8):911\u2013916","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"8888_CR56","doi-asserted-by":"publisher","first-page":"346","DOI":"10.4161\/epi.27582","volume":"9","author":"HM Vedeld","year":"2014","unstructured":"Vedeld HM, Skotheim RI, Lothe RA, Lind GE (2014) The recently suggested intestinal cancer stem cell marker DCLK1 is an epigenetic biomarker for colorectal cancer. Epigenetics 9(3):346\u2013350","journal-title":"Epigenetics"},{"issue":"3","key":"8888_CR57","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.ejpb.2014.10.006","volume":"88","author":"Q Yang","year":"2014","unstructured":"Yang Q, Zhang T, Wang C, Jiao J, Li J, Deng Y (2014) Coencapsulation of epirubicin and metformin in PEGylated liposomes inhibits the recurrence of murine sarcoma S180 existing CD133+ cancer stem-like cells. Eur J Pharm Biopharm 88(3):737\u2013745","journal-title":"Eur J Pharm Biopharm"},{"key":"8888_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3758","volume-title":"Molecular mechanisms of epithelial\u2013mesenchymal transition","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R (2014) Molecular mechanisms of epithelial\u2013mesenchymal transition. Nature Publishing Group"},{"key":"8888_CR59","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3389\/fonc.2018.00381","volume":"8","author":"K Weidenfeld","year":"2018","unstructured":"Weidenfeld K, Barkan D (2018) EMT and stemness in tumor dormancy and outgrowth: are they intertwined processes? Front Oncol 8:381","journal-title":"Front Oncol"},{"issue":"14","key":"8888_CR60","doi-asserted-by":"publisher","first-page":"16019","DOI":"10.1021\/acsami.0c23137","volume":"13","author":"C Qi","year":"2021","unstructured":"Qi C, Wang D, Gong X, Zhou Q, Yue X, Li C et al (2021) Co-delivery of curcumin and capsaicin by dual-targeting liposomes for inhibition of aHSC-induced drug resistance and metastasis. ACS Appl Mater Interfaces 13(14):16019\u201316035","journal-title":"ACS Appl Mater Interfaces"},{"issue":"70","key":"8888_CR61","doi-asserted-by":"publisher","first-page":"33403","DOI":"10.18632\/oncotarget.23607","volume":"9","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Xia L, Wang H, Oyang L, Su M, Liu Q et al (2018) Cancer stem cells in progression of colorectal cancer. Oncotarget 9(70):33403","journal-title":"Oncotarget"},{"key":"8888_CR62","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2147\/IJN.S270939","volume":"16","author":"Y-Q Chen","year":"2021","unstructured":"Chen Y-Q, Zhu W-T, Lin C-Y, Yuan Z-W, Li Z-H, Yan P-K (2021) Delivery of rapamycin by liposomes synergistically enhances the chemotherapy effect of 5-fluorouracil on colorectal cancer. Int J Nanomed 16:269\u2013281","journal-title":"Int J Nanomed"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-08888-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-023-08888-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-08888-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T17:04:08Z","timestamp":1700931848000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-023-08888-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,30]]},"references-count":62,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["8888"],"URL":"https:\/\/doi.org\/10.1007\/s11033-023-08888-2","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,30]]},"assertion":[{"value":"12 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was confirmed by the Hamadan University of Medical Sciences ethics committee (IR.UMSHA.REC.1399.266).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}